2013 Q1 Form 10-Q Financial Statement
#000114420413027499 Filed on May 09, 2013
Income Statement
| Concept | 2013 Q1 | 2012 Q1 |
|---|---|---|
| Revenue | $3.568M | $3.861M |
| YoY Change | -7.59% | -6.47% |
| Cost Of Revenue | $971.0K | $1.320M |
| YoY Change | -26.44% | 69.67% |
| Gross Profit | $2.997M | $2.408M |
| YoY Change | 24.46% | -53.89% |
| Gross Profit Margin | 84.0% | 62.37% |
| Selling, General & Admin | $2.103M | $1.630M |
| YoY Change | 29.02% | -18.09% |
| % of Gross Profit | 70.17% | 67.69% |
| Research & Development | $7.754M | $8.847M |
| YoY Change | -12.35% | -16.25% |
| % of Gross Profit | 258.73% | 367.4% |
| Depreciation & Amortization | $930.0K | $930.0K |
| YoY Change | 0.0% | 5.68% |
| % of Gross Profit | 31.03% | 38.62% |
| Operating Expenses | $9.857M | $8.847M |
| YoY Change | 11.42% | -16.25% |
| Operating Profit | -$4.429M | -$6.065M |
| YoY Change | -26.97% | 20.39% |
| Interest Expense | $110.0K | $160.0K |
| YoY Change | -31.25% | -1700.0% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $108.0K | |
| YoY Change | ||
| Pretax Income | -$4.320M | -$5.900M |
| YoY Change | -26.78% | 16.83% |
| Income Tax | $0.00 | $0.00 |
| % Of Pretax Income | ||
| Net Earnings | -$4.321M | -$5.904M |
| YoY Change | -26.81% | 16.86% |
| Net Earnings / Revenue | -121.1% | -152.91% |
| Basic Earnings Per Share | ||
| Diluted Earnings Per Share | -$0.47 | -$0.67 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 93.50M | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2013 Q1 | 2012 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $41.90M | $45.60M |
| YoY Change | -8.11% | -9.16% |
| Cash & Equivalents | $41.87M | $45.61M |
| Short-Term Investments | ||
| Other Short-Term Assets | $3.600M | |
| YoY Change | ||
| Inventory | $5.773M | $263.0K |
| Prepaid Expenses | ||
| Receivables | $1.698M | $815.0K |
| Other Receivables | $3.553M | $3.154M |
| Total Short-Term Assets | $52.89M | $49.84M |
| YoY Change | 6.13% | -20.0% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $15.71M | $17.51M |
| YoY Change | -10.29% | -1.09% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $1.300M | $1.100M |
| YoY Change | 18.18% | 10.0% |
| Total Long-Term Assets | $17.05M | $18.63M |
| YoY Change | -8.48% | 0.15% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $52.89M | $49.84M |
| Total Long-Term Assets | $17.05M | $18.63M |
| Total Assets | $69.94M | $68.46M |
| YoY Change | 2.16% | -15.37% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $3.800M | $4.600M |
| YoY Change | -17.39% | -38.67% |
| Accrued Expenses | ||
| YoY Change | ||
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $24.41M | $17.72M |
| YoY Change | 37.71% | -11.82% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $2.700M | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | $51.80M | $5.623M |
| YoY Change | 821.22% | -89.98% |
| Total Long-Term Liabilities | $51.82M | $57.20M |
| YoY Change | -9.41% | 1.96% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $24.41M | $17.72M |
| Total Long-Term Liabilities | $51.82M | $57.20M |
| Total Liabilities | $76.23M | $74.92M |
| YoY Change | 1.74% | -1.68% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | ||
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | -$6.283M | -$6.457M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $69.94M | $68.46M |
| YoY Change | 2.16% | -15.37% |
Cashflow Statement
| Concept | 2013 Q1 | 2012 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$4.321M | -$5.904M |
| YoY Change | -26.81% | 16.86% |
| Depreciation, Depletion And Amortization | $930.0K | $930.0K |
| YoY Change | 0.0% | 5.68% |
| Cash From Operating Activities | -$9.586M | -$6.281M |
| YoY Change | 52.62% | 57.5% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $642.0K | $810.0K |
| YoY Change | -20.74% | -68.89% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $47.00K | $42.00K |
| YoY Change | 11.9% | -8.7% |
| Cash From Investing Activities | -$689.0K | -$852.0K |
| YoY Change | -19.13% | -67.85% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $25.40M | |
| YoY Change | 23.3% | |
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | $25.57M | |
| YoY Change | 22.15% | |
| NET CHANGE | ||
| Cash From Operating Activities | -$9.586M | -$6.281M |
| Cash From Investing Activities | -$689.0K | -$852.0K |
| Cash From Financing Activities | $25.57M | |
| Net Change In Cash | -$10.28M | $18.44M |
| YoY Change | -155.72% | 28.98% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$9.586M | -$6.281M |
| Capital Expenditures | $642.0K | $810.0K |
| Free Cash Flow | -$10.23M | -$7.091M |
| YoY Change | 44.24% | 7.57% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2013Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2013Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2013Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
| CY2013Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | |
| CY2013Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-03-31 | |
| CY2013Q1 | dei |
Document Type
DocumentType
|
10-Q | |
| CY2013Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001006281 | |
| CY2013Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
93503268 | shares |
| CY2013Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
| CY2013Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
PROTALIX BIOTHERAPEUTICS, INC. | |
| CY2013Q1 | dei |
Trading Symbol
TradingSymbol
|
PLX | |
| CY2013Q1 | plx |
Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
|
28000 | USD |
| CY2012Q1 | plx |
Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
|
2000 | USD |
| CY2013Q1 | plx |
Depreciation Amortization And Asset Impairment
DepreciationAmortizationAndAssetImpairment
|
926000 | USD |
| CY2012Q1 | plx |
Depreciation Amortization And Asset Impairment
DepreciationAmortizationAndAssetImpairment
|
930000 | USD |
| CY2013Q1 | plx |
Grants And Reimbursements Received Or Receivable
GrantsAndReimbursementsReceivedOrReceivable
|
2431000 | USD |
| CY2012Q1 | plx |
Grants And Reimbursements Received Or Receivable
GrantsAndReimbursementsReceivedOrReceivable
|
2003000 | USD |
| CY2013Q1 | plx |
Increase In Liabilities For Property Plant And Equipment
IncreaseInLiabilitiesForPropertyPlantAndEquipment
|
815000 | USD |
| CY2012Q1 | plx |
Increase In Liabilities For Property Plant And Equipment
IncreaseInLiabilitiesForPropertyPlantAndEquipment
|
829000 | USD |
| CY2013Q1 | plx |
Number Of Subsidiaries
NumberOfSubsidiaries
|
2 | pure |
| CY2013Q1 | plx |
Other Gains Losses
OtherGainsLosses
|
400000 | USD |
| CY2012Q1 | plx |
Other Gains Losses
OtherGainsLosses
|
-133000 | USD |
| CY2013Q1 | plx |
Proceeds From Issuance Of Common Stock Net Of Expenses
ProceedsFromIssuanceOfCommonStockNetOfExpenses
|
USD | |
| CY2012Q1 | plx |
Proceeds From Issuance Of Common Stock Net Of Expenses
ProceedsFromIssuanceOfCommonStockNetOfExpenses
|
25538000 | USD |
| CY2013Q1 | plx |
Research Development And Engineering Expense Net
ResearchDevelopmentAndEngineeringExpenseNet
|
5323000 | USD |
| CY2012Q1 | plx |
Research Development And Engineering Expense Net
ResearchDevelopmentAndEngineeringExpenseNet
|
6844000 | USD |
| CY2012Q1 | plx |
Supplemental Offering And Stock Issuance Costs
SupplementalOfferingAndStockIssuanceCosts
|
150000 | USD |
| CY2013Q1 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
12055000 | USD |
| CY2012Q4 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
11051000 | USD |
| CY2013Q1 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
3762000 | USD |
| CY2012Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
5267000 | USD |
| CY2013Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1698000 | USD |
| CY2012Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1410000 | USD |
| CY2013Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
|
347000 | USD |
| CY2012Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
|
129000 | USD |
| CY2012Q1 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
1780000 | USD |
| CY2013Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
7471571 | shares |
| CY2012Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
7373768 | shares |
| CY2013Q1 | us-gaap |
Assets
Assets
|
69942000 | USD |
| CY2012Q4 | us-gaap |
Assets
Assets
|
78727000 | USD |
| CY2013Q1 | us-gaap |
Assets Current
AssetsCurrent
|
52894000 | USD |
| CY2012Q4 | us-gaap |
Assets Current
AssetsCurrent
|
61170000 | USD |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
41870000 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
52035000 | USD |
| CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
27001000 | USD |
| CY2012Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
45605000 | USD |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-10165000 | USD |
| CY2012Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
18604000 | USD |
| CY2013Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2012Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2012Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
| CY2012Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
| CY2013Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
971000 | USD |
| CY2012Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1320000 | USD |
| CY2013Q1 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
8591000 | USD |
| CY2012Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
9437000 | USD |
| CY2013Q1 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
46994000 | USD |
| CY2012Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
48888000 | USD |
| CY2013Q1 | us-gaap |
Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
|
1343000 | USD |
| CY2012Q4 | us-gaap |
Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
|
1247000 | USD |
| CY2013Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.05 | |
| CY2012Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.07 | |
| CY2013Q1 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
110000 | USD |
| CY2012Q1 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
163000 | USD |
| CY2013Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
108000 | USD |
| CY2012Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
161000 | USD |
| CY2013Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
78000 | USD |
| CY2012Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
114000 | USD |
| CY2013Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2103000 | USD |
| CY2012Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1629000 | USD |
| CY2013Q1 | us-gaap |
Gross Profit
GrossProfit
|
2997000 | USD |
| CY2013Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4429000 | USD |
| CY2012Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6065000 | USD |
| CY2012Q1 | us-gaap |
Gross Profit
GrossProfit
|
2408000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-3005000 | USD |
| CY2012Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-242000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
42000 | USD |
| CY2012Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1270000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-2740000 | USD |
| CY2012Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-2405000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1734000 | USD |
| CY2012Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-16000 | USD |
| CY2013Q1 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
3014000 | USD |
| CY2012Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1729000 | USD |
| CY2013Q1 | us-gaap |
Inventory Net
InventoryNet
|
5773000 | USD |
| CY2012Q4 | us-gaap |
Inventory Net
InventoryNet
|
4039000 | USD |
| CY2013Q1 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
2418000 | USD |
| CY2012Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
2118000 | USD |
| CY2013Q1 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
341000 | USD |
| CY2012Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
192000 | USD |
| CY2013Q1 | us-gaap |
Liabilities
Liabilities
|
76225000 | USD |
| CY2012Q4 | us-gaap |
Liabilities
Liabilities
|
82084000 | USD |
| CY2013Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
69942000 | USD |
| CY2012Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
78727000 | USD |
| CY2013Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
24408000 | USD |
| CY2012Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
25755000 | USD |
| CY2013Q1 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
51817000 | USD |
| CY2012Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
56329000 | USD |
| CY2013Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
2700000 | USD |
| CY2012Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
5425000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
USD | |
| CY2012Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
25574000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-689000 | USD |
| CY2012Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-852000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-9586000 | USD |
| CY2012Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6281000 | USD |
| CY2013Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4321000 | USD |
| CY2012Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5904000 | USD |
| CY2013Q1 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
3553000 | USD |
| CY2012Q4 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
3686000 | USD |
| CY2013Q1 | us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
47000 | USD |
| CY2012Q1 | us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
42000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
642000 | USD |
| CY2012Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
810000 | USD |
| CY2013Q1 | us-gaap |
Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
|
2123000 | USD |
| CY2012Q4 | us-gaap |
Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
|
2016000 | USD |
| CY2013Q1 | us-gaap |
Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
|
19000 | USD |
| CY2012Q1 | us-gaap |
Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
|
5000 | USD |
| CY2013Q1 | us-gaap |
Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
|
60000 | USD |
| CY2012Q1 | us-gaap |
Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
|
44000 | USD |
| us-gaap |
Proceeds From Collaborators
ProceedsFromCollaborators
|
60000000 | USD | |
| CY2013Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
USD | |
| CY2012Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
36000 | USD |
| CY2013Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
15705000 | USD |
| CY2012Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
16310000 | USD |
| CY2013Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7754000 | USD |
| CY2012Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8847000 | USD |
| CY2013Q1 | us-gaap |
Revenues
Revenues
|
3568000 | USD |
| CY2012Q1 | us-gaap |
Revenues
Revenues
|
3861000 | USD |
| CY2013Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1367000 | USD |
| CY2012Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
129000 | USD |
| CY2013Q1 | us-gaap |
Shares Outstanding
SharesOutstanding
|
93502230 | shares |
| CY2012Q4 | us-gaap |
Shares Outstanding
SharesOutstanding
|
93489809 | shares |
| CY2011Q4 | us-gaap |
Shares Outstanding
SharesOutstanding
|
85630157 | shares |
| CY2012Q1 | us-gaap |
Shares Outstanding
SharesOutstanding
|
90822252 | shares |
| CY2013Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6283000 | USD |
| CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3357000 | USD |
| CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-26077000 | USD |
| CY2012Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6457000 | USD |
| CY2012Q1 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
5175000 | shares |
| CY2013Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
12421 | shares |
| CY2012Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
17095 | shares |
| CY2013Q1 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
1020000 | USD |
| CY2012Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
25388000 | USD |
| CY2013Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
28000 | USD |
| CY2012Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
7000 | USD |
| CY2013Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
92184220 | shares |
| CY2012Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
87821078 | shares |
